Pharma Mar | PHM - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Almirall EUR 429.87M 180.02M 2025-12
Avita Medical AUD 14.31M 639K 2025-12
Dianthus Therapeutics USD 463K 179K 2026-03
Ionis Pharmaceuticals USD 243M 48M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Moderna USD -566M 792M 2026-03
Organon & Co USD 783M 71M 2026-03
Pharma Mar EUR 39.24M 47.46M 2026-03
Revvity USD 387.66M 34M 2026-03
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.38B 229.9M 2026-03
Xeris Pharmaceuticals USD 72.55M 404K 2026-03